Monday, June 15, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 317 of 1,261
  1. US 11110090

    Aminopyrimidines as ALK inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  2. US 11110099

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  3. US 11110093

    Sustained release small molecule drug formulation

    Indivior UK Limited · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  4. US 11110082

    Tyrosine kinase inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  5. US 11110067

    Inhibition of mammalian target of rapamycin

    The Board of Regents of the University of Texas System · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  6. US 11110060

    Compositions and methods for delivering pharmaceutical agents

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  7. US 11110063

    Storage stable sincalide formulations

    MAIA PHARMACEUTICALS, INC. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  8. US 11111238

    Coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer

    Lead Discovery Center GmbH · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  9. US 11111310

    Chimeric polypeptides and methods of altering the membrane localization of the same

    Cell Design Labs, Inc. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  10. US 11110080

    Small molecule inhibitors of bacterial efflux pumps and methods of using same

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  11. US 11110086

    Compounds useful as inhibitors of ATR kinase and combination therapies thereof

    Vertex Pharmaceuticals Incorporated · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  12. US 11111222

    Hydroxyeicosatrienoic acid compounds and their use as therapeutic agents

    The Regents of the University of California · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  13. US 11110089

    Pyridazinones and their use in the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  14. US 11110128

    Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo

    RegenLab USA LLC · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  15. US 11110092

    Methods of treating hematologic cancers

    BioCryst Pharmaceuticals, Inc. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  16. US 11110095

    Pyrimidine compounds as JAK kinase inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  17. US 11110108

    Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  18. US 11110177

    ASH1L degraders and methods of treatment therewith

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  19. US 11110178

    Antibody adjuvant conjugates

    Bolt Biotherapeutics, Inc. · Granted Sep 7, 2021 · Expires Sep 2, 2041

    granted
  20. IT 202000004582

    COMPOSIZIONE FARMACEUTICA UTILE PER IL TRATTAMENTO E LA PREVENZIONE DELL’ATROFIA E DELLA SECCHEZZA VAGINALE.

    ALFASIGMA SPA [IT] · Granted Sep 6, 2021 · Expires Sep 1, 2041

    granted
  21. US 11104684

    Dimers of covalent NFKB inhibitors

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  22. US 11103513

    Natural combination hormone replacement formulations and therapies

    Compass Therapeutics LLC · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  23. US 11103552

    High concentration VEGF receptor fusion protein containing formulations

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted
  24. US 11103541

    Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them

    Finch Therapeutics Holdings LLC · Granted Aug 31, 2021 · Expires Aug 26, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.